Efficacy of ClinproTMXT Varnish surrounding brackets on the enamel surface of white spot lesion

Abstract Orthodontics patients usual develop demineralization and present cavity caries lesions after six months. Minimally invasive procedures have been the goal in modern dental practice. The aim of this study was to evaluate the effect of ClinproTMXT Varnish, on the enamel surface roughness and severity of white spot lesions. Twenty premolars were submitted to bond brackets and experimental induction of demineralization and randomly divided into 2 groups: GI - fluoride varnish (Colgate Duraphat®); GII - Ionomeric Sealant (ClinproTMXT Varnish). The treatment was applied around the brackets. The surface roughness of specimens was analyzed, before treatment and 12 weeks after treatment by laser confocal microscopy, and the severity of the white spot lesion was by laser fluorescence device. The data were analyzed by non-parametric Wilcoxon and Mann-Whitney Test, at 5% significance, roughness percentage reduction was performed. The severity of demineralization decreased in both, GI (p = 0.005) and GII (p = 0.019). Enamel superficial roughness levels decreased in GI and GII. As well as the roughness percentage, being more expressive in the ClinproTMXT Varnish group (85,09%). Colgate Duraphat® or Clinpro™ XT Varnish reduced the severity of the demineralization and decreased the superficial roughness on the enamel. The Clinpro™ XT Varnish was superior to superficial roughness on enamel.

Resumo Pacientes ortodônticos geralmente desenvolvem desmineralização e apresentam lesões de cárie após seis meses de tratamento. Procedimentos minimamente invasivos têm sido o objetivo na prática odontológica moderna. O objetivo deste estudo foi avaliar o efeito do ClinproTM XT selante ionomérico, ao redor do bráquete, com relação a rugosidade superficial do esmalte e a severidade da lesão induzida. Vinte pré-molares foram submetidos a colagem de bráquetes e indução experimental de desmineralização e divididos aleatoriamente em 2 grupos: GI - verniz fluoretado (Colgate Duraphat®); GII - Selante Ionomérico (ClinproTM XT). O tratamento foi aplicado ao redor dos bráquetes. A rugosidade da superfície dos espécimes foi analisada, antes do tratamento e 12 semanas após o tratamento por microscopia confocal a laser e severidade da lesão de mancha branca por dispositivo de fluorescência a laser. Os dados foram analisados pelo teste não paramétrico de Wilcoxon e Mann-Whitney, a 5% de significância. A taxa de redução da lesão foi calculada. A severidade da desmineralização diminuiu tanto no GI (p = 0,005) quanto no GII (p = 0,019). Os níveis de rugosidade superficial do esmalte diminuíram no GI e GII, assim como o percentual de rugosidade, sendo mais expressivo no grupo ClinproTMXT (85,09%). Colgate Duraphat® e Clinpro™ XT reduziram a severidade da desmineralização e diminuíram a rugosidade superficial do esmalte. O selante ionomérico Clinpro™ XT foi superior na redução percentual de rugosidade.

Factores asociados a placa blanda en pacientes con score de calcio igual a cero / Factors Associated with Non-calcified Plaques in Patients with Coronary Artery Calcium Score of Zero

RESUMEN Introducción: El score de calcio es una prueba utilizada en la estratificación de riesgo de pacientes asintomáticos. Aunque la enfermedad coronaria puede producirse en ausencia de calcificaciones, no se han descripto afecciones asociadas a la presencia de placa blanda en este contexto, más allá de la presencia de síntomas. Objetivos: Determinar asociaciones entre la presencia de placa blanda y variables independientes en pacientes con un score de calcio de cero. Material y métodos: Se incluyeron pacientes consecutivos con un score de calcio de 0 unidades Agatston que se hubieran realizado, además, una angiotomografía coronaria. Se determinaron asociaciones a partir de análisis univariado. Se calculó la sensibilidad, especificidad, VPN, VPP, +LR y -LR. Resultados: Se incluyeron en el estudio 93 pacientes. El 10% (n = 9) presentaron placa blanda. La ergometría positiva se asoció a placas de cualquier gravedad (OR 6,5; IC del 95%: 1,3-33, p = 0,02). Esta asociación persistió para placas no graves cuando se combinó la ergometría positiva con perfusión miocárdica SPECT o ecocardiograma estrés negativos para isquemia (OR 12,4 IC 95% 1,5-101, p = 0,02). La sensibilidad y la especificidad del infradesnivel del ST para placa blanda de cualquier nivel de gravedad fue del 44,4% y del 86%, respectivamente. El VPN fue del 94% y el VPP del 25%, LR+ fue de 3,11 y LR- fue de 0,65. Conclusiones: El infradesnivel del ST se asociaría a la presencia de placa blanda en pacientes sin calcificaciones coronarias, incluso en contexto de perfusión miocárdica o motilidad parietal en esfuerzo normales (enfermedad no obstructiva).

ABSTRACT Background: The coronary artery calcium score is used for risk stratification in asymptomatic patients. Although coronary artery disease can occur in the absence of coronary artery calcifications, no conditions associated with the presence of soft non-calcified plaques have been described in this scenario, beyond the presence of symptoms. Objectives: The aim of this study was to determine the associations between non-calcified plaques and independent variables in patients with coronary artery calcium score of zero. Methods: Consecutive patients with coronary artery score of zero Agatston units who also underwent computed tomography coronary angiography were included in the study. Univariate logistic regression analysis was used to find associations. (15) Sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), positive likelihood ratio (LH+) and negative likelihood ratio (LH-) were calculated. Results: Among a total of 93 patients, 10% (n=9) presented non-calcified plaque. A positive exercise stress test was associated with plaques of any degree of severity (OR 6.5; 95% CI, 1.3-33, p=0.02). This association persisted for non-severe plaques when the positive exercise stress test was combined with a negative myocardial perfusion SPECT or stress echocardiography for ischemia (OR, 12.4; 95% CI 1.5-101, p=0.02). Sensitivity and specificity of ST-segment depression for non-calcified plaque of any degree of severity was 44.4% and 86%, respectively, with NPV of 94%, PPV of 25%, LR+ of 3.11 and LR- of 0.65. Conclusions: ST-segment depression could be associated with non-calcified plaques in patients without coronary artery calcifications, even with normal exercise stress myocardial perfusion or wall motion (non-obstructive disease).

Clinical and Molecular Study of the Extracellular Matrix Protein 1 Gene in a Spanish Family with Lipoid Proteinosis

BACKGROUND: Lipoid proteinosis (LP) is a rare autosomal recessive disorder characterized by a hoarse voice, variable scarring, and infiltration of the skin and mucosa. This disease is associated with mutations of the gene encoding extracellular matrix protein 1 (ECM1). CASE REPORT: This was a clinical and molecular study of a new case of LP with a severe phenotype. A 35-year-old female born to nonconsanguineous parents developed dermatological and extracutaneous symptoms in her 9th month of life. The neurological abnormalities of the disease began to appear at the age of 19 years. Computed tomography revealed cranial calcifications. CONCLUSIONS: The diagnosis of LP was confirmed by histopathological findings and direct sequencing of ECM1. A new homozygous nonsense mutation was identified in exon 7 of ECM1, c.1076G>A (p.Trp359*). This mutation was not detected in 106 chromosomes of healthy individuals with a similar demographic origin. Microsatellite markers around ECM1 were used to construct the haplotype in both the parents and the patient. Reports on genotype-phenotype correlations in LP point to a milder phenotype in carriers of missense mutations in the Ecm1a isoform, whereas mutations in the Ecm1b isoform are thought to be associated with more severe phenotypes. The present findings in a Spanish patient carrying a truncating mutation in exon 7 revealed complete dermatological and neurological manifestations.

Nefropatía por contraste en el síndrome coronario agudo / Contrast induced nephropathy in acute coronary syndrome

La nefropatía inducida por contraste (NIC) es una de las causas más frecuentes de insuficiencia renal en pacientes internados. En el síndrome coronario agudo (SCA), la presencia de NIC aumenta la morbimortalidad. Las medidas de profilaxis y los factores de riesgo intervinientes de NIC en SCA no han sido determinados con exactitud. El objetivo de este estudio fue evaluar la incidencia de NIC y los factores asociados a su desarrollo en pacientes ingresados en unidad coronaria con requerimiento de cinecoronariografía (CCG). Se realizó un estudio de cohorte retrospectivo. Se incluyeron pacientes consecutivos cursando SCA estudiados con CCG dentro de las 72 horas de su admisión. Se definió NIC al aumento del 25% del valor de creatinina a las 48 h sobre el nivel basal de ingreso. El período de inclusión fue entre el 1° de enero de 2004 hasta el 30 de junio de 2010. Se analizaron 125 casos. La incidencia de NIC fue del 10.4% (n = 13). En el análisis multivariado, los factores asociados independientemente a su desarrollo fueron la edad [OR 1.05 (IC 95% 1.004 - 1.11) p = 0.034], la angioplastia a múltiple vaso [OR 2.2 (IC 95% 1.07 - 4.8), p = 0.03] y el volumen de contraste utilizado [OR 1.007 (IC 95% 1.001 - 1.01), p = 0.014].

Contrast induced nephropathy (CIN) is one of the most frequent causes of acute renal failure in hospitalized patients. It is associated with an increase in morbidity and mortality in patients hospitalized for acute coronary syndrome (ACS) undergoing percutaneous coronary intervention (PCI). Risk factors and prevention strategies are not well defined. The aim of this study was to assess the incidence and clinical risk factors associated to the development of contrast induced nephropathy in patients hospitalized for ACS. In a retrospective cohort we analyzed consecutive patients hospitalized for ACS undergoing urgent PCI within 72 hours from the admission. CIN was defined as a 25% increase of creatinine levels from baseline at 48 hours from the PCI. The inclusion period was from January 1°, 2004 to June 30, 2010. A total of 125 patients were analyzed, and CIN occurred in 13 (10.4%) patients. An independent association was found between age (OR 1.05; 95% CI 1.004 to 1.11; p = 0.034), multiple vessel angioplasty (OR 2.2; 95% IC 1.07 to 4.8; p = 0.03) and the volume of contrast infused (OR 1.007; 95% CI 1.001 to 1.01; p = 0.014) with the development of CIN.